These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27017787)

  • 1. [Role of cytokines and their blocking in immune-mediated inflammatory diseases].
    Matikainen S; Jokiranta S; Eklund KK
    Duodecim; 2016; 132(4):349-54. PubMed ID: 27017787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review.
    Sozzani S; Abbracchio MP; Annese V; Danese S; De Pità O; De Sarro G; Maione S; Olivieri I; Parodi A; Sarzi-Puttini P
    Autoimmunity; 2014 Aug; 47(5):287-306. PubMed ID: 24697663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines & inflammation--GTCbio's seventh annual conference. 29-30 January 2009, San Diego, CA, USA.
    Fricker S
    IDrugs; 2009 Apr; 12(4):214-6. PubMed ID: 19350461
    [No Abstract]   [Full Text] [Related]  

  • 4. [Special features of biological drug therapy in children].
    Aalto K; Leinonen S; Kolho KL; Lahdenne P
    Duodecim; 2016; 132(4):377-82. PubMed ID: 27017790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
    Siebert S; Tsoukas A; Robertson J; McInnes I
    Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.
    Adelzadeh L; Jourabchi N; Wu JJ
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):846-52. PubMed ID: 25081573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune-Mediated Inflammatory Diseases and accompanying comorbidities].
    Majdan M
    Wiad Lek; 2016; 69(4):611-615. PubMed ID: 27941197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's New in Psoriasis.
    von Csiky-Sessoms S; Lebwohl M
    Dermatol Clin; 2019 Apr; 37(2):129-136. PubMed ID: 30850034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.
    Bosè F; Raeli L; Garutti C; Frigerio E; Cozzi A; Crimi M; Caprioli F; Scavelli R; Altomare G; Geginat J; Abrignani S; Reali E
    Clin Immunol; 2011 May; 139(2):164-76. PubMed ID: 21334981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
    Sfikakis PP
    Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.
    van den Berg WB; McInnes IB
    Semin Arthritis Rheum; 2013 Oct; 43(2):158-70. PubMed ID: 24157091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteins in rheumatology and clinical immunology].
    Villiger PM
    Ther Umsch; 2011 Nov; 68(11):603-9. PubMed ID: 22045522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interruption of biological drugs in patients affected with inflammatory diseases].
    Anttila VJ; Haapamäki J; Peltomaa R; Tiippana-Kinnunen T; Luosujärvi R
    Duodecim; 2016; 132(4):369-76. PubMed ID: 27017789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation: Treatment Progress and Limitations.
    Cascorbi I
    Clin Pharmacol Ther; 2017 Oct; 102(4):564-567. PubMed ID: 28895120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["TRECID", TNFalpha related chronic inflammatory diseases - a new multiple diseases bridging concept].
    Müller-Ladner U; Alten R; Heiligenhaus A; Kekow J; Koletzko S; Mrowietz U; Ochsenkühn T; Radke M; Reich K; Rudwaleit M; Schreiber S
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2132-6. PubMed ID: 19809965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokines and their antagonists in the treatment of rheumatoid arthritis].
    Klimiuk PA; Sierakowski S
    Przegl Lek; 2002; 59(2):108-12. PubMed ID: 12152246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New cytokine therapeutics for inflammatory bowel disease.
    Stokkers PC; Hommes DW
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):167-73. PubMed ID: 15588691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.